Biotricity, Inc. (BTCY) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Redwood City, CA, United States. The current CEO is Waqaas Al-Siddiq.
BTCY has IPO date of 2018-02-16, 55 full-time employees, listed on the Other OTC, a market capitalization of $7.68M.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.